Department
Dermatology
Burns, chronic wounds, skin grafts, dermatological inflammations
HBOT Applications
Chronic Non-Healing Wounds
Adjunctive HBOT for chronic non-healing wounds, including diabetic foot ulcers and vascular ulcers. Evidence base for chronic wound healing is the most robust dermatology application of HBOT.
Protocol
Pressure
2.0 – 2.5 ATA
Duration
60 – 90 min
Sessions
20 – 40
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
Radiation Dermatitis & Soft-Tissue Radiation Injury
Treatment for radiation dermatitis and delayed soft-tissue healing after radiotherapy. Promotes angiogenesis in hypoxic, hypovascular, hypocellular tissue.
Protocol
Pressure
2.0 – 2.5 ATA
Duration
60 – 90 min
Sessions
20 – 40
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
Compromised Skin Grafts & Flaps
Salvage adjunct for ischemic or venously congested skin grafts and flaps. Earlier initiation when perfusion issues are identified is associated with better outcomes; HBOT improves oxygen delivery, angiogenesis, fibroblast activity, and edema control.
Protocol
Pressure
2.0 – 2.5 ATA
Duration
60 – 90 min
Sessions
20 – 30
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
Burns & Necrotizing Soft-Tissue Infection
Adjunctive treatment for necrotizing fasciitis, Fournier's gangrene, and severe burns. Reduces mortality and tissue loss when combined with surgical debridement and antibiotic therapy.
Protocol
Pressure
2.0 – 2.5 ATA
Duration
90 min
Sessions
20 – 30
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
Inflammatory Dermatoses
Case-level and small-cohort evidence in atopic dermatitis (2025 review + paediatric study) and psoriasis (2009 case reports). Other inflammatory conditions (hidradenitis suppurativa, livedoid vasculopathy, pyoderma gangrenosum) have early-stage clinical reports but lack robust trials. HBOT is positioned as adjunctive, not first-line.
Protocol
Pressure
2.0 – 2.8 ATA
Duration
60 – 90 min
Sessions
6 – 30 (highly variable)
Frequency
Daily, protocol-dependent
Evidence basis: Case Reports & Small Studies